High expression of LOX and LOXL2 mRNA and protein is for the most part associated with poor prognosis in non-small cell lung cancer (NSCLC) patients [117,118,119,120] (Table 2). The gene discussed is LOXL2; the disease is non-small cell lung carcinoma.